NewAmsterdam Pharma Company N.V. Ordinary Shares Net Asset Momentum
NewAmsterdam Pharma Company N.V. Ordinary Shares net asset momentum. NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) recorded a net asset momentum of 162.7% as of December 2024, with net assets of $757.50 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore capital reinvestment ratio of NewAmsterdam Pharma Company N.V. Ordinar to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of NewAmsterdam Pharma Company N.V. Ordinary Shares (2020–2024)
Net asset momentum of NewAmsterdam Pharma Company N.V. Ordinary Shares from 2020 to 2024. This chart tracks NewAmsterdam Pharma Company N.V. Ordinary Shares's year-over-year net asset growth across 5 annual reporting periods from 2020 to 2024. The most recent momentum reading is +162.7%, with net assets of $757.50 Million USD as of December 2024. See NewAmsterdam Pharma Company N.V. Ordinar net assets for net asset value and shareholders' equity analysis.
NewAmsterdam Pharma Company N.V. Ordinary Shares Net Asset Momentum by Year (2020–2024)
NewAmsterdam Pharma Company N.V. Ordinary Shares net asset momentum by year from 2020 to 2024. The table below shows the complete annual net asset history for NewAmsterdam Pharma Company N.V. Ordinary Shares from 2020 to 2024, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market cap of NewAmsterdam Pharma Company N.V. Ordinar.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $757.50 Million | $864.62 Million | $107.12 Million | ▲ +162.7% |
| 2023 | $288.39 Million | $347.10 Million | $58.70 Million | ▼ -32.9% |
| 2022 | $430.07 Million | $478.50 Million | $48.43 Million | ▲ +659.5% |
| 2021 | $56.63 Million | $67.99 Million | $11.36 Million | ▼ -55.6% |
| 2020 | $127.46 Million | $139.87 Million | $12.41 Million | — |